Tetrabenazine
Chemical compound
Tetrabenazine is a drug for the symptomatic treatment of hyperkinetic movement disorders. It is sold under the brand names Nitoman and Xenazine among others. On August 15, 2008, the US Food and Drug Administration (FDA) approved the use of tetrabenazine to treat chorea associated with Huntington's disease.
Nº Q413050 ★
Common · Knowledge
Tetrabenazine
Chemical compound
Tetrabenazine is a drug for the symptomatic treatment of hyperkinetic movement disorders. It is sold under the brand names Nitoman and Xenazine among others. On August 15, 2008, the US Food and Drug Administration (FDA) approved the use of tetrabenazine to treat chorea associated with Huntington's disease.
Last price
—
Floor price
—
7-day median
—
30-day sales
0
30-day range
—
In circulation
0
Price history
median
low – high
sales
No sales in this period
Show table
| Date | median | Low | High | sales |
|---|
Sales history
- Last sale
- —
- 30-day average
- —
- 30-day low
- —
- 30-day high
- —
- Sales 7d
- 0
- Sales 30d
- 0
No sales yet.
Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.
From Wikipedia
Tetrabenazine is a drug for the symptomatic treatment of hyperkinetic movement disorders. It is sold under the brand names Nitoman and Xenazine among others. On August 15, 2008, the US Food and Drug Administration (FDA) approved the use of tetrabenazine to treat chorea associated with Huntington's disease. Although other drugs had been used "off-label", tetrabenazine was the first approved treatment for Huntington's disease in the United States. The compound has been known since the 1950s.
Text: Wikipédia, CC BY-SA 4.0. · Image: Ayacop (Public domain) ·
Related cards
Deutetrabenazine
Chemical compound
Nº Q27077026 ★
Prochlorperazine
Chemical compound
Nº Q2359690 ★★★
Alimemazine
Chemical compound
Nº Q2623251 ★★★★
Nusinersen
Pharmaceutical drug
Nº Q25105466 ★★
Tetracyclic antidepressant
Class of pharmaceutical drugs
Nº Q176564 ★★
Tetracaine
Chemical compound
Nº Q419608 ★